Twenty-two women with hyperprolactinemia and amenorrhea were followed up for at least 18 months after 22 bromocriptine-induced full term pregnancies.
Five of them conceived subsequently without any treatment. The prolactin (PRL) concentration before or during bromocriptine treatment was not significantly different between the patients who conceived spontaneously and those who did not.
However, the PRL concentration after weaning was significantly lower in the patients who conceived spontaneously than in those who did not. Serum PRL levels were normal or only slightly elevated in the patients who conceived spontaneously.
In 11 of the 22 patients, PRL levels were serially determined during bromocriptine-induced pregancies. In 7 of the 11 patients, serum PRL levels fell during the second or third trimester.
Spontaneous pregnancy occurred in 3 of the 7 patients who showed a decrease in PRL values during pregnancy, but in none of the 4 patients who did not.
Furthermore, PRL levels after weaning correlated with PRL levels during the third trimester in these 11 women. Consequently, a decrease in PRL values during pregnancy may result in a fall in PRL levels after pregnancy, which in turn leads to the restoration of reproductive function in some subjects.
Infertile women with hyperprolactinemic anovulation have successfully been treated with bromocriptine (Varga et al., 1973 ; Seki and Seki, 1974; Rolland et al., 1974) . Preexisting prolactinomas may be complicated by pregnancy-induced enlargement (Lamberts et al., 1977; Burty et al., 1978) .
However, previous studies have shown that hyperprolactinemic women are very unlikely to develop serious pituitary tumor complications during bromocriptine-induced pregnancy (Crosignani et al., 1981 ; Ruiz-Velasco and Tolis, 1984) . Furthermore, a resolution of hyperprolactinemia has been observed in some such patients after pregnancy (Cowden and Thompson, 1979; Noble, 1979; Crosignani et al., 1981 ; Rasmussen et al., 1985) . In an attempt to obtain further insight into the effects of pregnancy o prolactin (PRL) secretion in hyperprolactinemic women, we evaluated changes in PRL concentrations during and after bromo-criptine-induced pregnancies in these women in relation to their reproductive function after pregnancy.
Materials and Methods
Twenty-two unselected women, 24 to 39 years of age (median, 31 years), with amenorrhea and hyperprolactinemia were followed up for at least 18 months after 22 total bromocriptine-induced full term pregnancies (Table 1) . At the time of initial assessment, radiological examinations for pituitary tumor were performed with tomography and/or computed axial tomographic (CAT) scan of the sella turcica. Of the 22 patients, 4 had pituitary macroadenoma and 14 had pituitary microadenoma. In the remaining 4 patients, pituitary fossa was radiologically normal. These patients may have either functional hyperprolactinemia or an undetectable microadenoma. All four patients with macroadenoma and 2 of the 14 patients with microadenoma were treated with bromocriptine after surgery, since they continued to have hyperprolactinemia and amenorrhea after surgery.
The other 12 patients with microadenoma were treated with bromocriptine without prior surgery.
Serum PRL and estradiol (E2) levels were determined by radioimmunoassay as previously described (Seki et al., 1982) . The within-and between-assay coefficients of variation were both less than 10% in PRL as well as in E2 assays. The normal range of PRL was less than 25 ng/ml in nonpregnant women.
least two blood samples obtained.
All blood samples were obtained in the morning hours.
* after surgical treatment .
Treatment with bromocriptine was given in daily doses between 2.5 and 15 mg (median 5 mg) for 5 to 174 days (median, 85 days) before conception occurred.
In all patients, the treatment was stopped before or as soon as the diagnosis of pregnancy was made. The serum PRL concentration during bromocriptine treatment ranged between 4 and 24 ng/ml (median, 10 ng/ml)( Table  1 ). The PRL values during treatment represent the mean value for two samples collected just prior to the occurrence of pregnancy except for case 21 where only one sample was available. In all patients, the courses of pregnancies were uneventful. In 11 of the 22 patients, serum PRL and E2 levels were serially determined during pregnancy (Table 1, Nos. 1-11). All patients were allowed to breast-feed. No complications occurred during the lactation period.
After pregnancy and lactation, PRL was determined within 2 months after weaning. In most patients, the value was the mean for two samples. During follow-up, 5 women conceived without any treatment (Table 1, Nos. 1, 6, 7, 13, 21) . In 3 of them, serum PRL levels were also sequentially measured during the second, spontaneous pregnancies (Nos. 1, 6, 7).
Serum PRL levels were measured at monthly intervals in 20 normal women with uncomplicated pregnancies. The normal range of PRL is shown by the shaded area in Fig. 1 . Statistical analyses were performed using the signed rank test (Snedecor & Cochran, 1967) and regression analysis.
Results
Return of menstruation occurred after a period of breast-feeding in 9 of the 22 patients after bromocriptine-induced pregnancies. The remaining 13 patients had persisting amenorrhea. None of the patients performed contraception after pregnancy. Five of the 9 patients who regained menstruation conceived subsequently without any treatment. The dose and duration of bromocriptine treatment had not been significantly different in the patients who conceived spontaneously and those who did not ( Table 2 ). The PRL concentration before or during treatment was not significantly different in the two groups ( Table 2 ). The duration of lactation was also not significantly different in the two groups (Table  2) . However, the PRL concentration after weaning was significantly lower in the patients who conceived spontaneously compared to those who did not (Table 2) .
In 11 of the 22 hyperprolactinemic women, serum PRL levels were sequentially measured during bromocriptine-induced pregnancy (Table 1, Nos. 1-11). In 2 of the 3 patients with macroadenoma operated upon, PRL levels were higher than the normal range during the first trimester, fell during the Values are the median (range). NS, Not significant. second trimester, and were lower than the normal range during the third trimester (Fig.  1 , Nos. 1 and 2). The other patient with macroadenoma operated upon showed fluctuating PRL values with no rise throughout pregnancy (Fig. 1, No.3) .
In 1 of the 2 patients with microadenoma operated upon, serum PRL levels were higher than the normal range during the first trimester, fell during the second trimester, and were lower than the normal range during the third trimester (Fig. 1, No.4) .
In the other patient with microadenoma operated upon, serum PRL levels progressively rose until 20 weeks of pregnancy, and plateaued thereafter (Fig. 1, No.5) .
In 4 of the 6 patients with microadenoma without prior surgical treatment, serum PRL levels were higher than the normal range during the first trimester, fell during the second or third trimester, and were lower than the normal range during the third trimester (Fig . 1 , Nos. 6, 7, 10, 11) . The other 2 patients with microadenoma without prior surgical treatment showed either progressively increasing PRL values which were slightly higher than the normal range (Fig. 1, No.8 ) or fluctuating PRL values with a tendency to increase during pregnancy (Fig. 1, No.9) . In all 11 patients evaluated for E2, serum E2 levels progressively rose throughout pregnancy (Fig. 2) . PRL values (r=-0.42, n=11, p>0.05). Of the 5 patients who conceived spontaneously after bromocriptine-induced pregnancy, 4 patients were rescanned by CAT after lactation (Nos. 1, 6, 7, 11) . Although complete disappearance of the tumor image was noted in 1 patient (No. 6), no change was detected in the other 3 patients.
In 2 of the 3 patients evaluated for serial PRL levels during the second, spontaneous pregnancies, PRL levels were fluctuating with no marked rise throughout pregnancy (Fig. 3 , Nos. 1 and 7). In the other patient, PRL values increased until 23 weeks of pregnancy, and decreased thereafter (Fig. 3, No.6 ). after bromocriptine-induced pregnancy, and 5 of them conceived subsequently without any treatment. Serum PRL levels were normal or only slightly elevated in the patients who conceived spontaneously. The findings are in agreement with the results of other reported studies (Cowden and Thompson, 1979; Crosignani et al., 1981) . Furthermore, slightly elevated PRL levels do not appear to impair reproductive function in some subjects. The occurrence of the decrease in PRL values after pregnancy was independent of the pretreatment PRL value, the prepregnancy PRL value or the prior surgical treatment. PRL levels after weaning did not correlate with pretreatment PRL values or with prepregnancy PRL values. The decrease in PRL values after pregnancy was observed both in patients carrying microadenoma with and without prior surgical treatment.
However, the effect of prior surgical treatment cannot be ruled out in patients with macroadenoma, since such patients without prior surgical treatment were not evaluated in the present study.
In 7 of the 11 patients evaluated for PRL during pregnancy, serum PRL levels fell during the second or third trimester, and were lower than the normal range during the third trimester, though higher than the normal average range during the first trimester after withdrawal of bromocriptine. Of these 7 patients, 6 regained menstruation after pregnancy and 3 patients subsequently conceived. However, spontaneous pregnancy occurred in none of the 4 patients who failed to show a decrease in PRL values during pregnancy, though menstruation occurred in 1 of them.
Consequently, a decrease in PRL values during pregnancy may cause a decrease in PRL values after pregnancy, which may lead to the restoration of reproductive function in some subjects. This interpretation is supported by the finding that PRL levels after weaning correlated with PRL levels during the third trimester. In patient No.2, the decrease in PRL values during pregnancy might not be sufficient for the subsequent restoration of reproductive function. The occurrence of spontaneous pregnancy was independent of the duration of lactation, since the duration of lactation had not been significantly different in the patients who conceived spontaneously after bromocriptineinduced pregnancy from those who did not. The various patterns of serum PRL levels during bromocriptine-induced pregnancy cannot be explained by the difference in the degree of estrogen stimulation. Serum E2 levels rose during pregnancy in hyperprolactinemic women as in normal women. Thus, the mechanism for the decrease in the PRL concentration are not clear. However, the inadequacy of the hypophyseal blood supply due to pregnancy-related pituitary enlargement with subsequent partial infarction of the hyperfunctioning tissue suggested by Crosignani et al.(1981) appears plausible, since serum PRL levels were beyond the normal range during the first trimester in all patients whose PRL levels subsequently fell.
In 3 patients who conceived spontaneously, no change in the image of pituitary tumor was detected by CAT scanning performed after lactation.
Therefore, the disappearance of the pituitary tumor is not likely to be a prerequisite for the restoration of reproductive function.
The patients who conceived spontaneously after bromocriptine-induced pregnancy showed either fluctuating PRL levels or a decrease in PRL values during the spontaneous pregnancy. The latter pattern may reflect the response of persisting prolactinoma tissue to the stimulatory effect of pregnancy.
